Streetbeat News

Products Services

TM

FAW-Toyota, a joint venture between Toyota Motor Co (NYSE:TM) and China FAW Group Corporation, has issued a recall for over 12,000 bZ3 vehicles in China due to a door issue. The bZ3 battery-electric sedan was developed in collaboration with Warren Buffett-backed BYD and FAW Toyota. The company will replace the rear door's outer handle free of charge to customers.

Portfolio Pulse from Anan Ashraf

July 21, 2023 | 4:27 am

AAPL

Apple Inc. has reportedly unveiled its Vision Pro backend, setting the stage for the upcoming developer kit release. The backend for the Vision Pro battery will allow it to receive firmware updates and additional VisionOS assets. This coincides with the distribution of Apple's first-generation mixed-reality headset developer kits later this month. Apple previously announced that starting in July, developers could apply for Vision Pro development kits, which include a software 'Simulator' of Vision Pro, as part of their effort to prepare third-party apps for the headset's launch in early 2024.

Portfolio Pulse from Ananya Gairola

July 21, 2023 | 4:16 am

AMZN

META

US Representative Alexandria Ocasio-Cortez has announced her upcoming stream on Amazon's Twitch platform, sparking curiosity among Twitter users as to why she isn't choosing Twitter for streaming. The stream is scheduled for July 22, with Hasan Piker and other special guests. The announcement has also excited users of Meta Platforms' newly launched social media platform, Threads. Twitch recently faced backlash for implementing strict limitations on channel monetization, but reversed the changes due to the negative response.

Portfolio Pulse from Ananya Gairola

July 21, 2023 | 2:28 am

PARA

PARAA

Country music artist Jason Aldean's controversial song 'Try That In A Small Town' has been taken off the airwaves by CMT, owned by Paramount Global (NASDAQ:PARA)(NASDAQ:PARAA). The song, seen as pro-gun and pro-violence, has sparked controversy, leading to its removal from CMT's rotation. Despite this, the song has garnered nearly six million views on YouTube in six days. Several Republican presidential candidates have voiced their support for Aldean amidst the controversy.

Portfolio Pulse from Chris Katje

July 20, 2023 | 11:09 pm

KPOP

MCD

SBUX

Starbucks Corp (NYSE:SBUX) is partnering with K-pop group BLACKPINK to launch limited-time beverages and merchandise. The launch will begin on July 25 and will be centered on Starbucks locations in the Asia Pacific region. The partnership includes a new BLACKPINK-themed Strawberry Choco Cream flavored Frappuccino and 17 items of merchandise. The items will be available while supplies last at stores in Hong Kong, Indonesia, Korea, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vietnam.

Portfolio Pulse from Chris Katje

July 20, 2023 | 10:19 pm

EBS

Emergent BioSolutions has received US FDA approval for CYFENDUS, a two-dose anthrax vaccine for post-exposure prophylaxis use. The company has been delivering the vaccine to the U.S. Department of Health and Human Services since 2019 under pre-Emergency Use Authorization status.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 10:06 pm

AMZN

Andreea Matei has made close to $22,000 in eight months by reviewing Amazon.com, Inc. (NASDAQ:AMZN) products through the company's influencer program. The program pays members a commission based on sales that occur after a consumer watches a video review. Matei is averaging about $2,700 a month in passive income from her review videos, spending about three hours a week filming and editing content.

Portfolio Pulse from Adam Eckert

July 20, 2023 | 9:48 pm

TWTR

Twitter's Linda Yaccarino is set to introduce new safety features in the coming weeks to address advertisers' concerns about hate speech, according to the NY Post. The move is aimed at winning back advertisers.

Portfolio Pulse from Charles Gross

July 20, 2023 | 9:43 pm

CDNS

Cidara Therapeutics is continuing its collaboration with Janssen to complete Phase 1 and Phase 2a clinical trials. The trials are registered under the identifiers NCT05285137, NCT05619536, and NCT05523089.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 9:05 pm

CDTX

JNJ

Cidara Therapeutics announced that its partner, Janssen, plans to discontinue the majority of its infectious disease pipeline. However, Janssen has not indicated any intention to terminate its agreement with Cidara. The two companies continue to collaborate on Phase 1 and Phase 2a clinical trials, with Janssen reimbursing Cidara for all ongoing development activities.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 9:04 pm